REGN | Regeneron Pharmaceuticals
Category: Biotechnology company
Quick infos Headquarters: Tarrytown, New York, United States Trade prices Volume: 935K Market Cap: 65.4B Prev closed: 609.17 Open: 612.1 High: 630.76 Low: 608.76 52 week low: 271.37 52 week high: 646.33 Dividends: No Dividends Next ER: February 3, 2023 Before Market Opens
About the Company Regeneron Pharmaceuticals, Inc. is a biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988.
Earnings History Date EPS / Forecast Revenue / Forecast May 4, 2023 February 3, 2023 12.56 / 10.173.41B / 3.13BBeat! November 3, 2022 11.14 / 9.822.94B / 2.94BAugust 3, 2022 9.77 / 8.622.86B / 2.79BBeat! May 4, 2022 11.49 / 9.722.97B / 2.69BBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 16, 2022 648.70 643.49 649.77
639.70
602.89K 0.84% Aug 15, 2022 643.29 628.70 643.60
624.80
539.21K 2.32% Aug 12, 2022 628.71 628.87 632.57
622.30
351.28K 0.77% Aug 11, 2022 623.90 638.63 643.98
622.37
468.06K -2.74% Aug 10, 2022 641.49 630.00 645.95
624.78
681.69K 3.11% Aug 9, 2022 622.15 630.00 634.85
617.10
469.54K -1.34% Aug 8, 2022 630.63 619.78 633.93
618.87
715.23K 2.77% Aug 5, 2022 613.61 613.47 621.63
606.96
566.77K -0.22% Aug 4, 2022 614.96 602.65 623.35
602.65
695.07K 1.02% Aug 3, 2022 608.77 600.00 623.48
595.16
1.15M 5.88% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US75886F1075 CUSIP: 75886F107 Founded:1988 Employees:5,400 News
10 Latest Earnings That Surprised Wall Street finance.yahoo.com Jan 31, 2023 6:03 pm
Regeneron Stock Sinks on Disappointing Sales of Eylea Treatment finance.yahoo.com Jan 31, 2023 3:37 pm
CytomX (CTMX) Up 55% on Strategic Partnership With Moderna finance.yahoo.com Jan 31, 2023 1:46 pm
Market Update: KBH, REGN, UAL finance.yahoo.com Jan 31, 2023 12:59 pm
Peninsula biotech moves from layoffs to cancer-fighting deal with potential $2B payoff bizjournals.com Jan 31, 2023 11:09 am
Regeneron's (REGN) Libtayo Gets EC Nod for Cervical Cancer finance.yahoo.com Jan 31, 2023 10:41 am
15 Best S&P 500 Stocks That Dont Pay Dividends finance.yahoo.com Jan 31, 2023 10:39 am
Company News for Jan 10, 2023 finance.yahoo.com Jan 31, 2023 9:32 am
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent finance.yahoo.com Jan 31, 2023 9:06 am
Europe Approves Regeneron-Sanofi's Dupixent For Expanded Use In Eosinophilic Esophagitis finance.yahoo.com Jan 31, 2023 9:04 am
A Look At The Fair Value Of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) finance.yahoo.com Jan 31, 2023 9:01 am
Subdued Growth No Barrier To Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Price finance.yahoo.com Jan 31, 2023 9:00 am
Possible bearish signals as Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) insiders disposed of US$7.0m worth of stock finance.yahoo.com Jan 31, 2023 9:00 am
CytomX and Regeneron Announce Strategic Research Collaboration in the Field of Conditional Bispecific Therapeutics for the Treatment of Cancer finance.yahoo.com Jan 31, 2023 7:00 am
Regeneron ESMO IO Presentations Highlight Potential of Fianlimab and Libtayo® (cemiplimab) in Multiple Solid Tumor Types finance.yahoo.com Jan 31, 2023 7:00 am
Regeneron Highlights Its First Phase 2 Data To Build Case In CD20xC3 Bispecific Space finance.yahoo.com Jan 31, 2023 6:42 am UPDATE 1-Sanofi's and Regeneron's Dupixent wins new stage of EU regulatory approval finance.yahoo.com Jan 31, 2023 1:24 am
Dupixent® (dupilumab) Approved by European Commission as the First and Only Targeted Medicine Indicated for Prurigo Nodularis finance.yahoo.com Jan 31, 2023 12:59 am
Race is on to develop new generation of weight-loss drugs finance.yahoo.com Jan 31, 2023
15 Most Undervalued Quality Stocks To Buy According To Hedge Funds finance.yahoo.com Jan 26, 2023 9:16 am This company doesn't provide a dividend.
Key Persons CEO : Leonard S. Schleifer, MD, PhD Talk about Regeneron Pharmaceuticals below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.